+ Internal Medicine in Medellín · Neuro+
GLP-1
5
In-person appointment
Follow-up teleconsultation
+ Our specialist
Internist
Specialist in the medical management of obesity
+ Clinical internal medicine
A chronic, complex and multifactorial disease. It increases the risk of diabetes, high blood pressure, stroke, sleep apnea and cognitive decline. A comprehensive medical approach with new-generation medications.
Abdominal obesity, insulin resistance, high triglycerides, high blood pressure and cholesterol abnormalities. Therapeutic strategies to reduce cardiovascular risk.
GLP-1 agonists (Ozempic, Mounjaro) don’t just control blood sugar: they also produce weight loss and have proven cardiovascular benefits.
Evaluation and management of high blood pressure and cholesterol and triglyceride disorders, often associated with obesity.
COPD, rheumatologic diseases, hyperuricemia and gout, and hypothyroidism, often associated with weight gain.
Ozempic, Wegovy and Mounjaro prescribed and monitored with regular check-ups on dose, tolerability and results.
More on GLP-1 →+ Making the best decision
In that case, bariatric surgery usually produces better long-term results. The advantage of Neuro+ is that both options are available in the same center.
If during your medical treatment it turns out that surgery would be more beneficial, Dr. Andrés Velásquez can evaluate you without you having to look for another center.
+ Pharmacological management
Dual GLP-1/GIP agonist. The most potent option available today for the medical management of obesity.
Semaglutide approved specifically for the treatment of obesity in adults.
Weekly GLP-1 agonist for type 2 diabetes and obesity, with cardiovascular benefits.
Important: full details on each medication — mechanism, dosing, titration and clinical evidence — are on the medical obesity treatment page. The right medication for each person is determined by the physician based on their full clinical profile.
+ Multidisciplinary approach
Dr. Montoya (GLP-1) + Neurology (sleep study)
Dr. Montoya + Neurology — GLP-1 medications may reduce the frequency of migraine
Dr. Montoya (GLP-1 or comorbidity management) + Dr. Andrés Velásquez (surgery)
Dr. Montoya + Dr. Velásquez + Nutrition
+ Frequently asked questions
+ Book today